Sanofi
SNY
$42.78
$0.100.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 45.36B | 44.08B | |
| Total Other Revenue | -- | -- | 3.32B | 3.27B | |
| Total Revenue | -- | -- | 48.69B | 47.35B | |
| Cost of Revenue | -- | -- | 13.94B | 13.74B | |
| Gross Profit | -- | -- | 34.74B | 33.61B | |
| SG&A Expenses | -- | -- | 10.10B | 9.85B | |
| Depreciation & Amortization | -- | -- | 1.73B | 1.74B | |
| Other Operating Expenses | -- | -- | 4.58B | 4.03B | |
| Total Operating Expenses | -- | -- | 38.63B | 37.25B | |
| Operating Income | -- | -- | 10.06B | 10.10B | |
| Income Before Tax | -- | -- | 8.50B | 8.28B | |
| Income Tax Expenses | -- | -- | 1.63B | 1.67B | |
| Earnings from Continuing Operations | -- | -- | 6.87K | 6.61K | |
| Earnings from Discontinued Operations | -- | -- | 3.10B | 76.24M | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -69.78M | -69.42M | |
| Net Income | -- | -- | 9.90B | 6.62B | |
| EBIT | -- | -- | 10.06B | 10.10B | |
| EBITDA | -- | -- | 13.77B | 13.74B | |
| EPS Basic | -- | -- | 8.03 | 5.30 | |
| Normalized Basic EPS | -- | -- | 1.01 | -- | |
| EPS Diluted | -- | -- | 8.02 | 5.29 | |
| Normalized Diluted EPS | -- | -- | 1.01 | -- | |
| Average Basic Shares Outstanding | -- | -- | 4.96B | 4.99B | |
| Average Diluted Shares Outstanding | -- | -- | 4.96B | 5.00B | |
| Dividend Per Share | -- | -- | 4.18 | 4.18 | |
| Payout Ratio | -- | -- | 54.71% | -- | |